000 | 01997 a2200541 4500 | ||
---|---|---|---|
005 | 20250513104751.0 | ||
264 | 0 | _c19961226 | |
008 | 199612s 0 0 eng d | ||
022 | _a0277-3732 | ||
024 | 7 |
_a10.1097/00000421-199612000-00018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYeilding, A | |
245 | 0 | 0 |
_aAntiemetic efficacy of two different single intravenous doses of dolasetron in patients receiving high-dose cisplatin-containing chemotherapy. _h[electronic resource] |
260 |
_bAmerican journal of clinical oncology _cDec 1996 |
||
300 |
_a619-23 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 |
_aDiarrhea _xchemically induced |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Tolerance |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeadache _xchemically induced |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 |
_aQuinolizines _xadministration & dosage |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 |
_aVomiting _xchemically induced |
700 | 1 | _aBertoli, L | |
700 | 1 | _aEisenberg, P | |
700 | 1 | _aPlezia, P | |
700 | 1 | _aModiano, M R | |
700 | 1 | _aAlberts, D S | |
700 | 1 | _aKhojasteh, A | |
700 | 1 | _aCramer, M B | |
700 | 1 | _aHahne, W F | |
773 | 0 |
_tAmerican journal of clinical oncology _gvol. 19 _gno. 6 _gp. 619-23 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00000421-199612000-00018 _zAvailable from publisher's website |
999 |
_c8924100 _d8924100 |